Legislature(2013 - 2014)CAPITOL 106
04/03/2014 03:00 PM House HEALTH & SOCIAL SERVICES
| Audio | Topic |
|---|---|
| Start | |
| SB169 | |
| SB162 | |
| Adjourn |
* first hearing in first committee of referral
+ teleconferenced
= bill was previously heard/scheduled
+ teleconferenced
= bill was previously heard/scheduled
| *+ | HB 290 | TELECONFERENCED | |
| + | SB 162 | TELECONFERENCED | |
| + | TELECONFERENCED | ||
| += | SB 169 | TELECONFERENCED | |
SB 162-HYDROCODONE PRESCRIPTION BY OPTOMETRISTS
4:25:18 PM
CHAIR HIGGINS announced that the next order of business would be
SENATE BILL NO. 162, "An Act authorizing a licensed optometrist
to prescribe a pharmaceutical agent containing hydrocodone."
4:25:22 PM
DAVE SCOTT, Staff, Senator Donald Olson, Alaska State
Legislature, stated that the proposed bill created an exception
in law in case of federal action. Currently, optometrists were
entitled to prescribe hydrocodone for four day prescriptions.
The proposed bill did not change the scope of the practice of
optometry, however, as the U.S. Food and Drug Administration
(FDA) was considering a change for hydrocodone from Schedule III
to Schedule II, there would be a lapse in allowable coverage by
optometrists. He pointed out that there was a difference
between living in the bush and urban communities, especially
with access to optometrists. He noted that often a generalist
doctor needed to administer to eye injuries in rural Alaska,
until the patient could visit an eye specialist. He stated that
the mechanics of the proposed bill were to allow optometrists in
Alaska to continue to prescribe oxycodone in the event the FDA
decided to make any change.
4:28:26 PM
REPRESENTATIVE NAGEAK asked about the cost of hydrocodone versus
other similar alternative prescriptions.
MR. SCOTT replied that he did not know the costs.
REPRESENTATIVE NAGEAK asked about the availability for
hydrocodone versus the alternative prescriptions in the bush
communities.
MR. SCOTT replied that he did not know the availability.
4:29:29 PM
CHAIR HIGGINS [opened public testimony].
RACHEL REINHARDT, MD, American Academy of Ophthalmologists,
stated that she was the current president of the Washington
Academy of Eye Physicians and Surgeons. She reported that,
after several years of research, the FDA had recommended to the
U.S. Drug Enforcement Administration (DEA) to change hydrocodone
containing narcotics to a more restricted class. She shared
that the agencies concluded that there was a national crisis
with a 300 percent increase in prescription narcotics over the
past 20 years, and that hydrocodone was "at the top of that
list." She relayed that there had also been a 500 percent
increase for prescription narcotic deaths in the United States.
These prescription narcotic deaths now outnumbered the combined
total deaths from illegal narcotics, with Alaska ranking fifth
in the nation. She pointed out that one step toward a solution
was to restrict the number of providers who can prescribe these
narcotics. She addressed a possible concern that some rural
patients would suffer, stating that there were numerous
alternatives. She relayed that she prescribed other narcotics
such as codeine, as well as non-narcotic pain medications. She
relayed that a lot of painful eye conditions were treated with
bandages, contact lenses, and drops. She referred to a list of
15 non-narcotic pain medications as alternatives for moderate to
severe pain. She expressed her understanding to the concern for
rural areas. She addressed the proposed limitations to
prescriptions, which, although it sounded helpful, still allowed
access to the narcotics by a non-patient. She stated that the
medical community at large was responsible for the drug
epidemic, and this state of emergency had led to the "conscious,
intentional effort" to reclassify some drugs to a more
restrictive class, and thereby limit the number of providers
allowed to prescribe. She declared that this was about
protecting patients. She reported that prescription narcotic
deaths were the number one cause of unintentional death in the
United States, surpassing car accidents. She requested
opposition to SB 162.
REPRESENTATIVE KELLER pointed out that the Alaska State
Legislature had been working on a proposed bill for a database
of opioid prescriptions, which did not appear to having funding
to continue beyond July 1, 2014. He expressed his frustration
with this.
DR. REINHARDT replied that an increase to the number of
providers for these prescriptions would necessitate a database.
She stated that there also needed to be regular wide spread
distribution of medications for overdose. She offered to
voluntarily stop prescription of Vicodin [hydrocodone] just to
make a point to the dangers of prescription drug abuse.
4:38:15 PM
JEFF GONNASON, OD, Alaska Optometric Association, explained that
a controlled substance was a drug or chemical which was
regulated by the government, and classified according to
schedules for the potential of abuse. He said that each
schedule had a more restrictive prescription procedure,
including tighter record keeping and databases to track the
medication to prevent abuse. He reported that the Alaska State
Legislature, in 2000, had voted to authorize Alaska optometrists
to prescribe medications, including schedule II narcotics,
although this was subsequently vetoed by the governor. He noted
that a later law allowed prescriptions for Schedules III, IV,
and V narcotics, with a maximum 4-day supply, only for eye
conditions. He stated that this compromise had been acceptable
as eye pain was often acute, but resolved itself in less than
four days. He noted that hydrocodone combination drugs were
included in Schedule III. In response to an earlier question,
he said that these generic drugs were not very expensive. He
declared that there had been zero instances of abuse, and zero
complaints or actions by the state board or any other drug
enforcement agency against any Alaska optometrist. He
emphasized that these drugs were important for managing severe
eye pain. He pointed out that the proposed reclassification of
the drugs would "once again be the federal government regulation
overriding our state law." He stated that this drug was the
best tool for managing acute eye pain. He stressed that the
national drug abuse problem had nothing to do with Alaska
optometrists. He said that, as optometry was qualified and well
trained, people did not come to them for illicit drugs. He
expressed his disagreement with Dr. Reinhardt, stating that the
federal purpose was "to tighten the abuse potential from
problematic users," which he claimed did not include optometry
because of the restrictions. He offered an anecdote about an
incident in a rural community. He opined that the proposed bill
did not make any changes from the current practice by
optometrists in Alaska.
CHAIR HIGGINS asked if there was a medical doctor for
prescriptions in the bush communities.
DR. GONNASON replied that very often there was not a medical
doctor in the villages. He declared that he could go to a bush
clinic and not be allowed to give antibiotics, whereas a health
aide was allowed to give them.
4:44:46 PM
DAVID KARPIK, OD, President, Alaska Optometric Association,
stated that the Alaska Optometric Association supported SB 162.
He declared that the proposed bill was merely "a technical
addition to existing optometry law." He relayed that strong
measures already existed to prevent abuse by prescribers, and
tighter record keeping and tracking requirements also worked
toward this. He expressed his agreement with the problem for
addictions to prescription medications however, infrequent,
short term prescriptions were not contributing to this addiction
problem. He said there had been no complaints of abusive
prescribing of controlled substance toward optometrists in
Alaska in the seven years since statute had allowed the
prescription of controlled substances. He concluded that the
proposed bill maintained the opportunity for "continued,
compassionate relief of their eye related pain in an acute
setting."
4:47:56 PM
MR. SCOTT reported that the sponsor was well aware of the
concern for the abuse of prescription drugs. He noted that his
concern was assuaged by the four day limit on prescriptions. He
pointed out that Rural Alaska, without roads, was far more
inaccessible than rural Washington.
4:48:40 PM
CHAIR HIGGINS closed public testimony, and said that SB 162
would be held over.
| Document Name | Date/Time | Subjects |
|---|---|---|
| SB 162 - Sponsor Statement.pdf |
HHSS 4/3/2014 3:00:00 PM |
SB 162 |
| SB 162 Ver A.PDF |
HHSS 4/3/2014 3:00:00 PM |
SB 162 |
| SB 162 - Fiscal Note.PDF |
HHSS 4/3/2014 3:00:00 PM |
SB 162 |
| SB 162 - Lentfer support.PDF |
HHSS 4/3/2014 3:00:00 PM |
SB 162 |
| SB 162 - FDA announcement.PDF |
HHSS 4/3/2014 3:00:00 PM |
SB 162 |
| SB 162 - Dobson support.PDF |
HHSS 4/3/2014 3:00:00 PM |
SB 162 |
| SB 162 - Blower support.PDF |
HHSS 4/3/2014 3:00:00 PM |
SB 162 |
| SB 162 - AK Optometric Association.PDF |
HHSS 4/3/2014 3:00:00 PM |
SB 162 |
| SB 162 AKhydrocodoneHouseHessltrsb162-1.pdf |
HHSS 4/3/2014 3:00:00 PM |
SB 162 |
| SB 162 2013 Annual Drug Report.pdf |
HHSS 4/3/2014 3:00:00 PM |
SB 162 |
| SB 169 CS for HSS vsn H.pdf |
HHSS 4/3/2014 3:00:00 PM |
SB 169 |
| SB 169 Sectional CS vsn H.pdf |
HHSS 4/3/2014 3:00:00 PM |
SB 169 |
| SB 169 Support Dorius.pdf |
HHSS 4/3/2014 3:00:00 PM |
SB 169 |
| SB 169 Support Juneau Empire.pdf |
HHSS 4/3/2014 3:00:00 PM |
SB 169 |
| SB 169 Support Lily Lou.pdf |
HHSS 4/3/2014 3:00:00 PM |
SB 169 |
| CS SB 169 Version T.pdf |
HHSS 4/3/2014 3:00:00 PM HHSS 4/8/2014 3:00:00 PM |
SB 169 |
| SB 169 responses HHSS.pdf |
HHSS 4/3/2014 3:00:00 PM |
SB 169 |
| SB 169 Support Ilona Farr.pdf |
HHSS 4/3/2014 3:00:00 PM |
SB 169 |
| SB 169_Premera.pdf |
HHSS 4/3/2014 3:00:00 PM |
SB 169 |
| SB 169 Support AARP.pdf |
HHSS 4/3/2014 3:00:00 PM |
SB 169 |
| HCS for CSSB 169 ver T Explanation of Changes.pdf |
HHSS 4/3/2014 3:00:00 PM HHSS 4/8/2014 3:00:00 PM |
SB 169 |
| HCS for CSSB 169 ver T Section Analysis.pdf |
HHSS 4/3/2014 3:00:00 PM HHSS 4/8/2014 3:00:00 PM |
SB 169 |